Pfizer (PFE) to Defer Drug Price Increases Following Discussion with Trump
Tweet Send to a Friend
Following an extensive discussion with President Trump today, Pfizer’s (NYSE: PFE) Chairman and CEO Ian Read announced that it will ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE